Viewing Study NCT02404935


Ignite Creation Date: 2025-12-24 @ 10:02 PM
Ignite Modification Date: 2025-12-25 @ 7:39 PM
Study NCT ID: NCT02404935
Status: COMPLETED
Last Update Posted: 2022-03-24
First Post: 2015-03-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Treatment After Irinotecan-based Frontline Therapy: Maintenance With Erbitux (in Patients wtRAS mCRC)
Sponsor: UNICANCER
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module